T
he Editors are pleased to present the inaugural edition of JACC: Basic to Translational Science. Given the recent proliferation of journals, especially subspecialty cardiovascular journals, it is appropriate to question the need for a journal dedicated to bringing the fruits of fundamental scientific discoveries to patients. We find 2 compelling reasons to develop a journal that focuses on the critical interface between laboratory and clinical science. First, although a number of outstanding journals publish elegant scientific studies that seek to extend their findings in human biological samples, or that publish studies on novel devices or discoveries that can enter clinical trials, there has never been a scientific literary home for cardiovascular "translationalists" who wish to publish research that stands firmly at the crossroads of basic and clinical research. We do not seek to publish research that recapitulates the types of scientific studies that are published in existing high-impact scientific journals; rather, we will endeavor to publish those scientific studies that will lead to new therapies. More estab- for cardiovascular disease. Although we recognize that attaining a high-impact factor has become a customary de facto goal for scientific journals, we will measure our long-term success by the number of new 
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